Dipeptidyl-peptidase-4 Inhibitors for Treatment of Type 2 Diabetes

被引：0
|
作者：
Kripke, Clarissa
机构：
来源：
AMERICAN FAMILY PHYSICIAN | 2009年 / 79卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [1] Geospatial distribution of the adoption of dipeptidyl-peptidase-4 inhibitors for type 2 diabetes among Medicare beneficiaries
    Cordes, Jack
    Glynn, Robert J.
    Walker, Alexander M.
    Schneeweiss, Sebastian S.
    SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY, 2025, 52
  • [2] Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes
    Dengpiao Xie
    Qiqi Wang
    Wei Huang
    Liangbin Zhao
    European Journal of Clinical Pharmacology, 2023, 79 : 1291 - 1301
  • [3] Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes
    Xie, Dengpiao
    Wang, Qiqi
    Huang, Wei
    Zhao, Liangbin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (10) : 1291 - 1301
  • [4] Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
    Carolyn F. Deacon
    Nature Reviews Endocrinology, 2020, 16 : 642 - 653
  • [5] Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes
    Mikhail, Nasser
    CURRENT DRUG SAFETY, 2011, 6 (05) : 304 - 309
  • [6] Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
    Deacon, Carolyn F.
    NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (11) : 642 - 653
  • [7] Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
    Jang, Yun-Mi
    Kim, Dong-Lim
    DIABETES & METABOLISM JOURNAL, 2011, 35 (02) : 117 - 118
  • [8] Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    Wood, Lindy
    Campbell, R. Keith
    PHARMACOTHERAPY, 2010, 30 (05): : 463 - 484
  • [9] Dipeptidyl-peptidase-4 Inhibitors in Type 2 Diabetes and COVID-19: From a Potential Repurposed Agent to a Useful Treatment Option
    Singh, Awadhesh Kumar
    Singh, Ritu
    JOURNAL OF DIABETOLOGY, 2020, 11 (03) : 131 - 136
  • [10] Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: Focus on sitagliptin
    Herman, G. A.
    Stein, P. P.
    Thornberry, N. A.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 761 - 767
12345